These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 25851070)

  • 21. Adverse effects in children exposed to maternal HIV and antiretroviral therapy during pregnancy in Brazil: a cohort study.
    Delicio AM; Lajos GJ; Amaral E; Cavichiolli F; Polydoro M; Milanez H
    Reprod Health; 2018 May; 15(1):76. PubMed ID: 29747664
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antiretroviral Therapy in Relation to Birth Outcomes among HIV-infected Women: A Cohort Study.
    Li N; Sando MM; Spiegelman D; Hertzmark E; Liu E; Sando D; Machumi L; Chalamilla G; Fawzi W
    J Infect Dis; 2016 Apr; 213(7):1057-64. PubMed ID: 26265780
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Correlates and outcomes of preterm birth, low birth weight, and small for gestational age in HIV-exposed uninfected infants.
    Slyker JA; Patterson J; Ambler G; Richardson BA; Maleche-Obimbo E; Bosire R; Mbori-Ngacha D; Farquhar C; John-Stewart G
    BMC Pregnancy Childbirth; 2014 Jan; 14():7. PubMed ID: 24397463
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Premature delivery in HIV-infected women starting protease inhibitor therapy during pregnancy: role of the ritonavir boost?
    Sibiude J; Warszawski J; Tubiana R; Dollfus C; Faye A; Rouzioux C; Teglas JP; Ekoukou D; Blanche S; Mandelbrot L
    Clin Infect Dis; 2012 May; 54(9):1348-60. PubMed ID: 22460969
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Congenital anomalies and in utero antiretroviral exposure in human immunodeficiency virus-exposed uninfected infants.
    Williams PL; Crain MJ; Yildirim C; Hazra R; Van Dyke RB; Rich K; Read JS; Stuard E; Rathore M; Mendez HA; Watts DH;
    JAMA Pediatr; 2015 Jan; 169(1):48-55. PubMed ID: 25383770
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Maternal HIV-1 disease progression 18-24 months postdelivery according to antiretroviral prophylaxis regimen (triple-antiretroviral prophylaxis during pregnancy and breastfeeding vs zidovudine/single-dose nevirapine prophylaxis): The Kesho Bora randomized controlled trial.
    Kesho Bora Study Group
    Clin Infect Dis; 2012 Aug; 55(3):449-60. PubMed ID: 22573845
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Risk factors for very preterm delivery and delivery of very-small-for-gestational-age infants among HIV-exposed and HIV-unexposed infants in Botswana.
    Parekh N; Ribaudo H; Souda S; Chen J; Mmalane M; Powis K; Essex M; Makhema J; Shapiro RL
    Int J Gynaecol Obstet; 2011 Oct; 115(1):20-5. PubMed ID: 21767835
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Birth prevalence of congenital cytomegalovirus among infants of HIV-infected women on prenatal antiretroviral prophylaxis in South Africa.
    Manicklal S; van Niekerk AM; Kroon SM; Hutto C; Novak Z; Pati SK; Chowdhury N; Hsiao NY; Boppana SB
    Clin Infect Dis; 2014 May; 58(10):1467-72. PubMed ID: 24567248
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pregnancy Outcomes in the Era of Universal Antiretroviral Treatment in Sub-Saharan Africa (POISE Study).
    Dadabhai S; Gadama L; Chamanga R; Kawalazira R; Katumbi C; Makanani B; Dula D; Hua N; Lau B; Mallewa M; Taha TE
    J Acquir Immune Defic Syndr; 2019 Jan; 80(1):7-14. PubMed ID: 30272628
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Maternal antiretroviral drugs during pregnancy and infant low birth weight and preterm birth.
    Szyld EG; Warley EM; Freimanis L; Gonin R; Cahn PE; Calvet GA; Duarte G; Melo VH; Read JS;
    AIDS; 2006 Nov; 20(18):2345-53. PubMed ID: 17117021
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pregnancy and neonatal outcomes among a cohort of HIV-infected women in a large Italian teaching hospital: a 30-year retrospective study.
    Grignolo S; Agnello R; Gerbaldo D; Gotta C; Alicino C; Del Puente F; Taramasso L; Bruzzone B; Gustavino C; Trasino S; DE Maria A; Icardi G; Viscoli C; DI Biagio A
    Epidemiol Infect; 2017 Jun; 145(8):1658-1669. PubMed ID: 28325171
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Emulating a target trial of antiretroviral therapy regimens started before conception and risk of adverse birth outcomes.
    Caniglia EC; Zash R; Jacobson DL; Diseko M; Mayondi G; Lockman S; Chen JY; Mmalane M; Makhema J; Hernán MA; Shapiro RL
    AIDS; 2018 Jan; 32(1):113-120. PubMed ID: 29112066
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Factors associated with sub-microscopic placental malaria and its association with adverse pregnancy outcomes among HIV-negative women in Dar es Salaam, Tanzania: a cohort study.
    Kalinjuma AV; Darling AM; Mugusi FM; Abioye AI; Okumu FO; Aboud S; Masanja H; Hamer DH; Hertzmark E; Fawzi WW
    BMC Infect Dis; 2020 Oct; 20(1):796. PubMed ID: 33109111
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Time to viral load suppression in antiretroviral-naive and -experienced HIV-infected pregnant women on highly active antiretroviral therapy: implications for pregnant women presenting late in gestation.
    Aziz N; Sokoloff A; Kornak J; Leva NV; Mendiola ML; Levison J; Feakins C; Shannon M; Cohan D
    BJOG; 2013 Nov; 120(12):1534-47. PubMed ID: 23924192
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of alcohol consumption and psychosocial stressors on preterm and small-for-gestational-age births in HIV-infected women in South Africa: a cohort study.
    Sania A; Brittain K; Phillips TK; Zerbe A; Ronan A; Myer L; Abrams EJ
    BMJ Open; 2017 Mar; 7(3):e014293. PubMed ID: 28320796
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of antiretroviral therapy on pregnancy outcome in HIV-1 positive women.
    Kowalska A; Niemiec T; El Midaoui A; Burkacka E
    Med Wieku Rozwoj; 2003; 7(4 Pt 1):459-68. PubMed ID: 15010556
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Risk factors for preterm birth among HIV-infected pregnant Ugandan women randomized to lopinavir/ritonavir- or efavirenz-based antiretroviral therapy.
    Koss CA; Natureeba P; Plenty A; Luwedde F; Mwesigwa J; Ades V; Charlebois ED; Clark TD; Achan J; Ruel T; Nzarubara B; Kamya MR; Havlir DV; Cohan D
    J Acquir Immune Defic Syndr; 2014 Oct; 67(2):128-35. PubMed ID: 25072616
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Altered angiogenesis as a common mechanism underlying preterm birth, small for gestational age, and stillbirth in women living with HIV.
    Conroy AL; McDonald CR; Gamble JL; Olwoch P; Natureeba P; Cohan D; Kamya MR; Havlir DV; Dorsey G; Kain KC
    Am J Obstet Gynecol; 2017 Dec; 217(6):684.e1-684.e17. PubMed ID: 29031892
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The effect of ethnicity and maternal birthplace on small-for-gestational-age deliveries to HIV-infected women.
    Cocroft JR; Hauck WW; Cosler L; Turner BJ
    J Urban Health; 2002 Mar; 79(1):147-60. PubMed ID: 11937623
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Perinatal outcomes associated with maternal HIV and antiretroviral therapy in pregnancies with accurate gestational age in South Africa.
    Santosa WB; Staines-Urias E; Tshivuila-Matala COO; Norris SA; Hemelaar J
    AIDS; 2019 Aug; 33(10):1623-1633. PubMed ID: 30932959
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.